Sexual Enhancement Product Recalled for Undeclared Prescription Drugs
Pyramids Wholesale Inc. is recalling HONEY MANUKA BUNNY LOVE nationwide because it contains undeclared sildenafil and/or tadalafil—prescription medications—and was marketed without FDA approval.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification requires a minimum severity score of 4. While no deaths or serious injuries have been reported, the undeclared presence of prescription medications sildenafil and/or tadalafil poses serious potential health risks through drug interactions and contraindications with certain medical conditions.
Plain-English summary
Pyramids Wholesale Inc. is recalling HONEY MANUKA BUNNY LOVE, a 12-gram sexual enhancement product, distributed nationwide in the United States. The recall affects all lots of the product.
The recall was issued because the product contains undeclared sildenafil and/or tadalafil—prescription medications used to treat erectile dysfunction—and was marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA) from the FDA. The presence of these undeclared prescription drugs poses a serious health risk, as these medications can interact with other drugs and medical conditions.
Consumers who have purchased this product should stop using it. Anyone who has questions or who has consumed this product and is experiencing health concerns should consult a healthcare provider.
The recalled product
- Product
- HONEY MANUKA BUNNY LOVE, 12g, All Natural Sexual Enhancement, UPC: N/A
- Manufacturer
- Pyramids Wholesale Inc.
- Category
- Drug — Sexual Enhancement
- Hazard
- undeclared-prescription-drug
- drug-interaction-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27